<code id='67C6646329'></code><style id='67C6646329'></style>
    • <acronym id='67C6646329'></acronym>
      <center id='67C6646329'><center id='67C6646329'><tfoot id='67C6646329'></tfoot></center><abbr id='67C6646329'><dir id='67C6646329'><tfoot id='67C6646329'></tfoot><noframes id='67C6646329'>

    • <optgroup id='67C6646329'><strike id='67C6646329'><sup id='67C6646329'></sup></strike><code id='67C6646329'></code></optgroup>
        1. <b id='67C6646329'><label id='67C6646329'><select id='67C6646329'><dt id='67C6646329'><span id='67C6646329'></span></dt></select></label></b><u id='67C6646329'></u>
          <i id='67C6646329'><strike id='67C6646329'><tt id='67C6646329'><pre id='67C6646329'></pre></tt></strike></i>

          focus

          focus

          author:entertainment    Page View:25
          Mitch McConnell, after the 81-year-old GOP leader froze at the microphones as he arrived for a news conference, at the Capitol in Washington. -- health coverage from STAT
          J. Scott Applewhite/AP

          The handling of Senate Minority Leader Mitch McConnell’s abrupt medical issue this week is raising concerns among medical experts that the event sent a potentially dangerous public-health message — that when someone experiences an episode with symptoms like McConnell’s, they can simply return to work as though nothing had happened.

          McConnell experienced the episode on Wednesday — freezing and remaining silent for about 20 seconds during a press conference, then showing signs of disorientation — and was led away by aides while cameras rolled.

          advertisement

          Minutes later, the Kentucky senator, 81, returned to the press briefing and said, “I’m fine.” He didn’t answer specific questions about whether he was examined by a doctor. A McConnell aide later said the senator had felt light-headed.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Novo: Oral version of Ozempic leads to 15% weight loss
          Novo: Oral version of Ozempic leads to 15% weight loss

          LISELOTTESABROE/AFP/GettyImagesAnoralversionofsemaglutide,thedrugmarketedasOzempicandWegovy,ledtodra

          read more
          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more

          Micronoma's microbiome cancer diagnostic approach under fire

          Amedicalillustrationofdrug-resistant,Streptococcuspneumoniaebacteria.AntibioticResistanceCoordinatio